Results 121 to 130 of about 30,100 (294)
Erwiderung auf Herrn Dr. G. Behrend's Aufsatz: „Ueber Nervenläsion und Haarausfall mit Bezug auf die Alopecia areata” [PDF]
Max Joseph
openalex +1 more source
Alopecia areata and autoimmunity: A clinical study
Alopecia areata (AA) frequently occur in association with other autoimmune diseases such as thyroid disorders, anemias and other skin disorders with autoimmune etiology.
Thomas Emy, Kadyan R
doaj
Background: Alopecia areata is a common autoimmune disorder which is characterized by non-scarring hair loss. Vitamin D plays an important role in immune regulation, cell growth, differentiation, and maintenance of hair cycle. Aims and Objectives: (1) To
Harsha Siddappa +2 more
doaj +1 more source
ABSTRACT Mesenchymal stromal cells (MSCs) exert their effects primarily through paracrine signaling via soluble factors and extracellular vesicles (EVs), especially exosomes. These acellular components offer regenerative and immunomodulatory benefits with fewer safety and logistical constraints than cell‐based therapies.
Marcela da Costa Pereira Cestari +2 more
wiley +1 more source
Ueber Alopecia areata und über die Veränderung der Haare bei derselben [PDF]
Gustav Behrend
openalex +1 more source
What Is the Diagnostic Capacity of Existing Severity Scoring Tools for Nail Psoriasis?
ABSTRACT Background It is challenging to distinguish nail psoriasis (NP) from nonspecific nail changes, contributing to heterogeneity in clinical trials. Existing scoring tools for NP are currently used to assess severity after diagnosis is established.
Evi C. C. Rikken +5 more
wiley +1 more source
A study of serum prolactin in dermatological diseases in a tertiary care hospital of Assam
Background: Prolactin functions as a neuroendocrine modulator of the skin immune system and epithelial cell proliferation. Prolactin and the immune system inter relationship have been studied extensively and opened new avenues in the field of ...
Talukdar C, Boro B
doaj +1 more source
ABSTRACT Background Patients with alopecia areata (AA) in ALLEGRO‐2b/3 (NCT03732807) had clinically significant hair regrowth and patient‐reported improvements with ritlecitinib versus placebo, but patient‐reported improvements in AA Patient Priority Outcomes (AAPPO) emotional symptoms (ES) or activity limitations (AL) were not observed during the 24 ...
Ernest H. Law +8 more
wiley +1 more source

